The biotech market in the United States is experiencing a substantial surge in requirement for Tirzepatide APIs. This potent medication, used to treat type 2 diabetes, has gained extensive attention from both patients and healthcare professionals. As a result, numerous manufacturers have emerged as producers of Tirzepatide APIs in the USA. Well-